The DOI matches its Crossref record.
Down's syndrome: Is there a decreased population of neurons?
Abstract
Although gross abnormalities have been described in the brains of patients with Down's syndrome (DS), microscopic studies have revealed only minor and inconsistent findings. We compared two DS brains, in whole-brain serial sections, with similarly prepared age- and sex-matched normal controls. Architectonic abnormalities were noted, and cell counts revealed a significant poverty of granular cells in the DS brains, particularly in granular fields such as areas 3, 17, and 41. Golgi studies demonstrated all major cell types. A striking feature of the brain morphology in DS may be the curtailment of a specific cell type, most likely the aspinous stellate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The fetal cortex, cerebellum and hippocampus have all been shown to contain fewer neurons in individuals with DS than in controls40–48, albeit based on small sample sizes17.”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [46]
In the citing paper
“Several studies have shown that fewer interneurons are present in the cortex of individuals with DS44,46,84 than in that of controls, suggesting that reduced generation of interneurons contributes to the overall reduced neurogenesis in DS.”
From Consequences of trisomy 21 for brain development in Down syndrome (2024) · cites this paper as [46]
In the citing paper
“The hypocellularity persists with fewer total neurons being identified in the superior temporal gyrus in adolescents and adults with DS (15–35 years) (Ross et al., 1984; Giffin-Rao et al., 2020).”
From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Ross et al., 1984
In the citing paper
“Broadly, one study has identified a decreased number of aspinous stellate interneurons in young adults with DS (Ross et al., 1984).”
From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Ross et al., 1984
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Geschwind, N. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060060019009 · Cited by 1,773
Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
Busciglio, J., & Yankner, B. A. (1995) · Nature · doi:10.1038/378776a0 · Cited by 741
A Prospective Study of Alzheimer Disease in Down Syndrome
Lai, F., & Williams, R. S. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520440031017 · Cited by 561
Analysis of neocortex in three males with the Fragile X syndrome
Hinton, V. J., Brown, W. T., Wisniewski, K., & Rudelli, R. D. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320410306 · Cited by 527
The pathological association between down syndrome and Alzheimer disease
Mann, D. M. A. (1988) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(88)90041-3 · Cited by 346
Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome
Belichenko, P. V., Masliah, E., Kleschevnikov, A. M., Villar, A. J., Epstein, C. J., Salehi, A., & Mobley, W. C. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20337 · Cited by 297
Wisniewski, K. E. (2005) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320370755 · Cited by 297
Contestabile, A., Fila, T., Ceccarelli, C., Bonasoni, P., Bonapace, L., Santini, D., Bartesaghi, R., & Ciani, E. (2007) · Hippocampus · doi:10.1002/hipo.20308 · Cited by 281
Dendritic atrophy in children with down’s syndrome.
Becker, L. E., Armstrong, D. L., & Chan, F. (1986) · Annals of Neurology · doi:10.1002/ana.410200413 · Cited by 279
Guidi, S., Bonasoni, P., Ceccarelli, C., Santini, D., Gualtieri, F., Ciani, E., & Bartesaghi, R. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00113.x · Cited by 276
Ballard, C. G., Mobley, W. C., Hardy, J., Williams, G. H., & Corbett, A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00063-6 · Cited by 289
Human astrocytes in the diseased brain
Dossi, E., Vasile, F., & Rouach, N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.02.001 · Cited by 250
The neurobiologie consequences of down syndrome
Coyle, J. T., Oster-Granite, M. L., & Gearhart, J. D. (1986) · Brain Research Bulletin · doi:10.1016/0361-9230(86)90074-2 · Cited by 248
Mann, D. M. A., Yates, P. O., & Marcyniuk, B. (1985) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(85)90129-7 · Cited by 240
Hof, P. R. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540280065020 · Cited by 242
The Role of Cell Death in Regulating the Size and Shape of the Mammalian Forebrain
Haydar, T. F. (1999) · Cerebral Cortex · doi:10.1093/cercor/9.6.621 · Cited by 242
Bahn, S., Mimmack, M., Ryan, M., Caldwell, M. A., Jauniaux, E., Starkey, M., Svendsen, C. N., & Emson, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07497-4 · Cited by 211
Deficits in human trisomy 21 iPSCs and neurons
Weick, J. P., Held, D. L., Bonadurer, G. F., Doers, M. E., Liu, Y., Maguire, C., Clark, A., Knackert, J. A., Molinarolo, K., Musser, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216575110 · Cited by 205
Xu, R., Brawner, A. T., Li, S., Liu, J.-J., Kim, H., Xue, H., Pang, Z. P., Kim, W.-Y., Hart, R. P., Liu, Y., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.04.014 · Cited by 193
Human Models Are Needed for Studying Human Neurodevelopmental Disorders
Zhao, X., & Bhattacharyya, A. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.10.009 · Cited by 192
Zhou, C. J., Qiu, Y., Pereira, F. A., Crair, M. C., Tsai, S. Y., & Tsai, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)81032-6 · Cited by 190
Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer’s disease
Rissman, R. A., & Mobley, W. C. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07237.x · Cited by 174
Guidi, S., Ciani, E., Bonasoni, P., Santini, D., & Bartesaghi, R. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00459.x · Cited by 165
Teipel, S. J., Alexander, G. E., Schapiro, M. B., Möller, H., Rapoport, S. I., & Hampel, H. J. (2004) · Brain · doi:10.1093/brain/awh101 · Cited by 154
Protocols to establish genotype-phenotype correlations in Down syndrome.
Epstein, C. J., Korenberg, J. R., Annerén, G., Antonarakis, S. E., Aymé, S., Courchesne, E., Epstein, L. B., Fowler, A. E., Groner, Y., & Huret, J. L. (1991) · PubMed · Cited by 144
Tang, X.-Y., Xu, L., Wang, J., Hong, Y., Wang, Y., Zhu, Q., Wang, D., Zhang, X.-Y., Liu, C.-Y., Fang, K.-H., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci135763 · Cited by 143
The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome
Contestabile, A., Magara, S., & Cancedda, L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00054 · Cited by 141
Aneuploidy: From a Physiological Mechanism of Variance to Down Syndrome
Dierssen, M., Hérault, Y., & Estivill, X. (2009) · Physiological Reviews · doi:10.1152/physrev.00032.2007 · Cited by 143
Dendrites, dementia and the down syndrome
Takashima, S., Ieshima, A., Nakamura, H., & Becker, L. E. (1989) · Brain and Development · doi:10.1016/s0387-7604(89)80082-8 · Cited by 132
Dendritic and histochemical development and ageing in patients with Down's syndrome
TAKASHIMA, S., IIDA, K., MITO, T., & ARIMA, M. (1994) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1994.tb00394.x · Cited by 126
Huo, H.-Q., Qu, Z.-Y., Yuan, F., Ma, L., Yao, L., Xu, M., Hu, Y., Ji, J., Bhattacharyya, A., Zhang, S.-C., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.02.001 · Cited by 122
Neurogenesis impairment: An early developmental defect in Down syndrome
Stagni, F., Giacomini, A., Emili, M., Guidi, S., & Bartesaghi, R. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.026 · Cited by 120
Aziz, N. M., Guedj, F., Pennings, J. L. A., Olmos-Serrano, J. L., Siegel, A., Haydar, T. F., & Bianchi, D. W. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031013 · Cited by 118
Esposito, G., Imitola, J., Lu, J., De Filippis, D., Scuderi, C., Ganesh, V. S., Folkerth, R., Hecht, J., Shin, S., Iuvone, T., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm322 · Cited by 115
Trazzi, S., Mitrugno, V. M., Valli, E., Fuchs, C., Rizzi, S., Guidi, S., Perini, G., Bartesaghi, R., & Ciani, E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr033 · Cited by 114
Down Syndrome: Advances in Molecular Biology and the Neurosciences
Capone, G. T. (2001) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200102000-00007 · Cited by 110
SEIZURES IN CHILDREN WITH DOWN SYNDROME: ETIOLOGY, CHARACTERISTICS AND OUTCOME
Stafstrom, C. E., Patxot, O. F., Gilmore, H. E., & Wisniewski, K. E. (1991) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1991.tb05108.x · Cited by 108
INFANTILE SPASMS IN CHILDREN WITH DOWN SYNDROME
Stafstrom, C. E., & Konkol, R. J. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11894.x · Cited by 105
Hyperkalemia during Anesthesia
Wisniewski, K. E., Laure‐Kamionowska, M., & Wisniewski, H. M. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411013111818 · Cited by 105
Chapter 4 Alzheimer's Disease in Adults with Down Syndrome
Zigman, W. B., Devenny, D. A., Krinsky‐McHale, S. J., Jenkins, E. C., Urv, T. K., Węgiel, J., Schupf, N., & Silverman, W. P. (2008) · International review of research in mental retardation · doi:10.1016/s0074-7750(08)00004-9 · Cited by 106
VISUAL ACUITY IN INFANTS AND CHILDREN WITH DOWN SYNDROME
Courage, M. L., Adams, R. J., Reyno, S. M., & Kwa, P. G. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11895.x · Cited by 94
Najas, S., Arranz, J., Lochhead, P. A., Ashford, A. L., Oxley, D., Delabar, J. M., Cook, S. J., Barallobre, M. J., & Arbonés, M. L. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.01.010 · Cited by 92
Silencing Trisomy 21 with XIST in Neural Stem Cells Promotes Neuronal Differentiation
Czerminski, J. T., & Lawrence, J. B. (2020) · Developmental Cell · doi:10.1016/j.devcel.2019.12.015 · Cited by 95
Lu, J., Esposito, G., Scuderi, C., Steardo, L., Delli-Bovi, L. C., Hecht, J. L., Dickinson, B. C., Chang, C. J., Mori, T., & Sheen, V. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022126 · Cited by 91
Oxidative stress and neural dysfunction in Down Syndrome
Iannello, R. C., Crack, P. J., de Haan, J. B., & Kola, I. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_17 · Cited by 90
Reduced cell number in the neocortical part of the human fetal brain in Down syndrome
Larsen, K. B., Laursen, H., Græm, N., Samuelsen, G. B., Bogdanovic, N., & Pakkenberg, B. (2008) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2008.05.007 · Cited by 87
Anderson, A. J., Stoltzner, S., Lai, F., Su, J. H., & Nixon, R. A. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00126-3 · Cited by 88
Excessive expression of synaptojanin in brains with Down syndrome
Arai, Y., Ijuin, T., Takenawa, T., Becker, L. E., & Takashima, S. (2002) · Brain and Development · doi:10.1016/s0387-7604(01)00405-3 · Cited by 86
Park, J., Oh, Y., & Chung, K. C. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.1.006 · Cited by 86
Pérez-Cremades, D., Hernández, S., Blasco-Ibáñez, J. M., Crespo, C., Nacher, J., & Varea, E. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0376-9 · Cited by 85
Impaired myelination of the human hippocampal formation in Down syndrome
Ábrahám, H., Vincze, A., Veszprémi, B., Kravják, A., Gömöri, É., Kovács, G. G., & Seress, L. (2012) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.11.005 · Cited by 85
Role of Founder Cell Deficit and Delayed Neuronogenesis in Microencephaly of the Trisomy 16 Mouse
Haydar, T. F., Nowakowski, R. S., Yarowsky, P., & Krueger, B. K. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04156.2000 · Cited by 84
Evidence of Arrest of Neurogenesis and Synaptogenesis in Brains of Patients with Down's Syndrome
(1984) · New England Journal of Medicine · doi:10.1056/nejm198411013111819 · Cited by 82
Cao, S.-Y., Hu, Y. F., Chen, C. Y., Yuan, F., Xu, M., Li, Q., Fang, K.-H., Chen, Y., & Liu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-03519-w · Cited by 84
Discrepancy between Alzheimer‐Type Neuropathology and Dementia in Persons with Down's Syndromea
Wı́sniewski, H. M., & Rabe, A. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb40344.x · Cited by 81
Reflex Seizures are Frequent in Patients with Down Syndrome and Epilepsy
Guerrini, R., Genton, P., Bureau, M., Dravet, C., & Roger, J. (1990) · Epilepsia · doi:10.1111/j.1528-1157.1990.tb05496.x · Cited by 80
Bhattacharyya, A., McMillan, E., Chen, S. I., Wallace, K., & Svendsen, C. N. (2009) · Developmental Neuroscience · doi:10.1159/000236899 · Cited by 79
Karlsen, A. S., & Pakkenberg, B. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr033 · Cited by 75
Is it possible to improve neurodevelopmental abnormalities in Down syndrome?
Bartesaghi, R., Guidi, S., & Ciani, E. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.037 · Cited by 77
Sweeney, J. E., Höhmann, C. F., Oster‐Granite, M. L., & Coyle, J. T. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90384-9 · Cited by 73
Can neural selectionism be applied to cognitive development and its disorders?
Johnson, M. H., & Karmiloff‐Smith, A. (1992) · New Ideas in Psychology · doi:10.1016/0732-118x(92)90046-3 · Cited by 74
Karrer, J. H., Karrer, R., Bloom, D., Chaney, L., & Davis, R. (1998) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(98)00015-4 · Cited by 72
The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's Disease
Iulita, M. F., & Cuello, A. C. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150921100030 · Cited by 69
Consequences of Trisomy 16 for Mouse Brain Development: Corticogenesis in a Model of Down Syndrome
Haydar, T. F., Blue, M. E., Molliver, M. E., Krueger, B. K., & Yarowsky, P. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-19-06175.1996 · Cited by 66
Regional Cerebral Glucose Metabolism is Normal in Young Adults with down Syndrome
Schapiro, M. B., Grady, C. L., Kumar, A., Herscovitch, P., Haxby, J. V., Moore, A. M., White, B. J., Friedland, R. P., & Rapoport, S. I. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.35 · Cited by 65
GVS‐111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons
Pelsman, A., Hoyo‐Vadillo, C., Гудашева, Т. А., Середенин, С. Б., Ostrovskaya, R. U., & Busciglio, J. A. (2003) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(03)00031-5 · Cited by 65
Saito, Y., Oka, A., Mizuguchi, M., Motonaga, K., Mori, Y., Becker, L. E., Arima, K., Miyauchi, J., & Takashima, S. (2000) · Acta Neuropathologica · doi:10.1007/s004010000230 · Cited by 65
Neuronal Proliferation, Migration, Organization, and Myelination
Volpe, J. J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3995-2.10002-0 · Cited by 66
Small planum temporale volume in Down's syndrome: a volumetric MRI study
Frangou, S., Aylward, E., Warren, A., Sharma, T., Barta, P. E., & Pearlson, G. D. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.10.1424 · Cited by 65
GABAergic over-inhibition, a promising hypothesis for cognitive deficits in Down syndrome
Martín, J. Z. D. S., Delabar, J. M., Bacci, A., & Potier, M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.002 · Cited by 70
Normal Neurogenesis but Abnormal Gene Expression in Human Fragile X Cortical Progenitor Cells
Bhattacharyya, A., McMillan, E., Wallace, K., Tubon, T. C., Capowski, E. E., & Svendsen, C. N. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0073 · Cited by 61
Loss of neurones from cortical and subcortical areas in Down's syndrome patients at middle age
Mann, D. M. A., Yates, P. O., Marcyniuk, B., & Ravindra, C. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90223-1 · Cited by 61
Koo, B. K. K., Blaser, S., Harwood-Nash, D., Becker, L. E., & Murphy, E. G. (1992) · Journal of Child Neurology · doi:10.1177/088307389200700417 · Cited by 59
Souchet, B., Duchon, A., Gu, Y., Dairou, J., Chevalier, C., Daubigney, F., Nalesso, V., Créau, N., Yu, Y., Janel, N., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40328-9 · Cited by 54
Treating enhanced GABAergic inhibition in Down syndrome: Use of GABA α5-selective inverse agonists
Martínez-Cué, C., Delatour, B., & Potier, M.-C. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.12.008 · Cited by 58
Brain size and cerebral glucose metabolic rate in nonspecific mental retardation and down syndrome
Haier, R. J., Chueh, D., Touchette, P. E., Lott, I. T., Buchsbaum, M. S., MacMillan, D. L., Sandman, C. A., LaCasse, L., & Sosa, E. (1995) · Intelligence · doi:10.1016/0160-2896(95)90032-2 · Cited by 58
Höhmann, C. F., Kwiterovich, K. K., Oster‐Granite, M. L., & Coyle, J. T. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.2.143 · Cited by 56
(2011) · PubMed · Cited by 57
Cortical differentiation and neurocognitive development: The parcellation conjecture
Johnson, M. H., & Vecera, S. P. (1996) · Behavioural Processes · doi:10.1016/0376-6357(95)00028-3 · Cited by 56
Mouse Models for Down Syndrome-Associated Developmental Cognitive Disabilities
Liu, C., Belichenko, P. V., Zhang, L., Fu, D., Kleschevnikov, A. M., Baldini, A., Antonarakis, S. E., Mobley, W. C., & Yu, Y. E. (2011) · Developmental Neuroscience · doi:10.1159/000329422 · Cited by 57
Gath, A. (1986) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1986.tb14294.x · Cited by 53
Horwitz, B., Schapiro, M. B., GRADY, C. L., & Рапопорт, С. И. (1990) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1990.tb01535.x · Cited by 51
Neurodevelopment in Down syndrome: Concordance in humans and models
Klein, J. A., & Haydar, T. F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.941855 · Cited by 47
Recent Advances in the Genetics of Epilepsy: Insights from Human and Animal Studies
Prasad, A. N., Prasad, C., & Stafstrom, C. E. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb02004.x · Cited by 47
Down Syndrome in Neurobiological Perspective: An Emphasis on Spatial Cognition
Uecker, A., Mangan, P. A., Obrzut, J. E., & Nadel, L. (1993) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp2202_12 · Cited by 46
Mann, D. M. A., Royston, M. C., & Ravindra, C. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90152-d · Cited by 46
Trazzi, S., Fuchs, C., Valli, E., Perini, G., Bartesaghi, R., & Ciani, E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.451088 · Cited by 46
RetractedBachman, E. S., Berger-Sweeney, J. E., Coyle, J. T., & Höhmann, C. F. (1994) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(94)90071-x · Cited by 43
Altered Distribution of Hippocampal Interneurons in the Murine down Syndrome Model Ts65Dn.
Hernández-González, S., Ballestín, R., López-Hidalgo, R., Gilabert-Juan, J., Blasco-Ibáñez, J. M., Crespo, C., Nácher, J., & Varea, E. (2015) · Neurochemical Research · doi:10.1007/s11064-014-1479-8 · Cited by 41
Moldrich, R. X., Dauphinot, L., Laffaire, J., Vitalis, T., Hérault, Y., Beart, P. M., Rossier, J., Vivien, D., Gehrig, C., Antonarakis, S. E., et al. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22131 · Cited by 43
Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.
Schapiro, M. B., Haxby, J. V., Grady, C. L., Duara, R., Schlageter, N. L., White, B., Moore, A., Sundaram, M., Larson, S. M., & Рапопорт, С. И. (1987) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.6.766 · Cited by 41
Chapter 4 Age-related changes in Down syndrome brain and the cellular pathology of Alzheimer disease
Williams, R. S., & Matthysse, S. (1986) · Progress in brain research · doi:10.1016/s0079-6123(08)64297-1 · Cited by 40
Altered patterning of trisomy 21 interneuron progenitors
Giffin-Rao, Y., Sheng, J., Strand, B., Xu, K., Huang, L., Medo, M., Risgaard, K. A., Dantinne, S., Mohan, S., Keshan, A., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.05.001 · Cited by 38
Brain myo-inositol level is elevated in Ts65Dn mouse and reduced after lithium treatment
Huang, W., Galdzicki, Z., van Gelderen, P., Balbo, A., Chikhale, E. G., Schapiro, M. B., & Rapoport, S. I. (2000) · Neuroreport · doi:10.1097/00001756-200002280-00004 · Cited by 38
Węgiel, J., Flory, M. J., Kuchna, I., Nowicki, K., Wegiel, J., Ma, S. Y., Zhong, N., Wierzba‐Bobrowicz, T., de Leon, M., Lai, F., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01300-9 · Cited by 35
Auditory evoked potentials in Down's syndrome
Dı́az, F., & Zurrón, M. (1995) · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section · doi:10.1016/0013-4694(95)00080-i · Cited by 35
Valbuena, S., García, Á., Mazier, W., Paternain, A. V., & Lerma, J. (2019) · Nature Communications · doi:10.1038/s41467-019-13004-9 · Cited by 32
Topography of nerve cell loss from the locus caeruleus in middle aged persons with Down's syndrome
Marcyniuk, B., Mann, D. M. A., Yates, P. O., & Ravindra, C. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90016-0 · Cited by 32
The neuroanatomy of mental retardation in the white rat
Thompson, R. H., Huestis, P. W., Crinella, F. M., & Yu, J. (1986) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(86)90016-3 · Cited by 32
Use of toxins to disrupt neurotransmitter circuitry in the developing brain
Johnston, M. V., Barks, J., Greenamyre, T., & Silverstein, F. S. (1988) · Progress in brain research · doi:10.1016/s0079-6123(08)60519-1 · Cited by 30
Metadata
- Authors
- Ross, M. H., Galaburda, A. M., & Kemper, T. L.
- Affiliations
- Boston University (US)
- Venue
- Neurology
- Published
- 1984-07
- Volume
- 34
- Issue
- 7
- Pages
- 909-909
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2054562862
- Cited by
- 191
- References
- 0
- Citations by year
- 2025: 5 · 2024: 4 · 2023: 5 · 2022: 9 · 2021: 4 · 2020: 2 · 2019: 5 · 2018: 6 · 2017: 7 · 2016: 2 · 2015: 5 · 2014: 3 · 2013: 2 · 2012: 2
- FWCI
- 12.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Developmental Neuroscience › Williams Syndrome Research
- Keywords
- Down syndrome, brain architecture, neuronal cell counts, granular cells, brain structure, Golgi staining, cerebral cortex
- MeSH terms
- Adult, Auditory Cortex, Brain, Child, Down Syndrome, Female, Humans, Male, Somatosensory Cortex, Visual Cortex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review